NASDAQ: CINGCingulate Inc Stock Ownership - Who owns Cingulate?
Insider buying vs selling
Have Cingulate Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jennifer L. Callahan | Corporate Controller | 2023-05-15 | 2,000 | $1.01 | $2.02kBuy |
| Jennifer L. Callahan | Corporate Controller | 2023-05-12 | 4,000 | $1.08 | $4.32kBuy |
| Shane J. Schaffer | Chief Executive Officer | 2022-12-16 | 10,000 | $1.02 | $10.17kBuy |
| Shane J. Schaffer | Chief Executive Officer | 2022-12-14 | 13,267 | $1.01 | $13.40kBuy |
| Jennifer L. Callahan | Corporate Controller | 2022-12-14 | 7,548 | $0.99 | $7.46kBuy |
| Peter J. Werth | Director | 2022-12-13 | 28,934 | $0.98 | $28.41kBuy |
| Shane J. Schaffer | Chief Executive Officer | 2022-12-13 | 1,733 | $1.01 | $1.75kBuy |
| Jennifer L. Callahan | Corporate Controller | 2022-11-29 | 1,530 | $0.98 | $1.50kBuy |
| Jennifer L. Callahan | Corporate Controller | 2022-11-28 | 3,487 | $0.98 | $3.42kBuy |
| Craig S. Gilgallon | EVP GC and Secretary | 2022-11-23 | 3,575 | $0.84 | $3.00kBuy |
CING insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CING insiders and whales buy or sell their stock.
CING Shareholders
What type of owners hold Cingulate Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Peter J. Werth | 8.52% | 997,014 | $936.20k | Insider |
| Shane J. Schaffer | 7.26% | 849,328 | $797.52k | Insider |
| Werth Family Investment Associates LLC | 7.15% | 836,431 | $785.41k | Insider |
| Fountainhead Shrugged LLC | 6.90% | 807,828 | $758.55k | Insider |
| Matthew Brams | 5.56% | 650,240 | $610.58k | Insider |
| Raul R. Silva | 3.99% | 467,232 | $438.73k | Insider |
| Craig S. Gilgallon | 1.66% | 194,846 | $182.96k | Insider |
| Gregg Wm Givens | 1.49% | 174,318 | $163.68k | Insider |
| Horn Louis G. Van | 1.34% | 156,606 | $147.05k | Insider |
| Vanguard Group Inc | 1.05% | 123,016 | $115.51k | Institution |
CING vs Biotech Stocks
Cingulate Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.